You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 137 No. 2, February 2001 TABLE OF CONTENTS
  Archives
  •  Online Features
  The Cutting Edge: Challenges in Medical and Surgical Therapeutics
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (20)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Dermatology
 •Dermatology, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Low-Dose Interferon Alfa-2b for the Treatment of Churg-Strauss Syndrome With Prominent Skin Involvement

Christian C. Termeer, MD; Jan C. Simon, MD; Erwin Schöpf, MD

Arch Dermatol. 2001;137:136-138.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

REPORT OF A CASE

A 68-year-old man presented with a medical history of recurrent bronchial asthma and sinusitis maxillaris. He had a severe bronchial infection that was treated with a combination product of sulfamethoxazole and trimethoprim and subsequently with cefadroxil in combination with low-dose (20 mg/d of prednisolone) therapy for treatment of the asthma. Three weeks after discontinuation of of antibiotic therapy but continuation of use of prednisolone, 20 mg/d, he developed severe bronchial asthma, sinusitis, systemic hypereosinophilia, and characteristic granulomatous skin lesions on the upper half of the back, in the axilla and inguinal region, rapidly expanding within days (Figure 1A). Skin lesions consisted of sharply marginated, erythematous plaques of dull red with a central clearing and a centrifugal spread (Figure 1A). The patient reported occasional mild pruritus. The presumptive diagnosis of Churg-Strauss syndrome (CSS) was confirmed by . . . [Full Text of this Article]

THERAPEUTIC CHALLENGE

SOLUTION

COMMENT



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Antineutrophil Cytoplasmic Antibody-Associated Vasculitides and Respiratory Disease
Gomez-Puerta et al.
Chest 2009;136:1101-1111.
ABSTRACT | FULL TEXT  

Intrinsic pathway of apoptosis in peripheral blood eosinophils of Churg-Strauss syndrome
Jakiela et al.
Rheumatology (Oxford) 2009;48:1202-1207.
ABSTRACT | FULL TEXT  

Interferons and Their Application in Lung Diseases
Kroegel et al.
Chest 2003;124:2406-2407.
FULL TEXT  

Churg-Strauss Syndrome Associated With Fluticasone Therapy
Termeer et al.
Arch Dermatol 2001;137:1527-1528.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.